ArticleCancer management and research2019
Gemcitabine, cisplatin, prednisone, and thalidomide for relapse and refractory peripheral T-cell lymphoma: a retrospective study from China.
Xiangli Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.